Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion type Assertion NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_head.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion description "[HL60 cells were exposed to clinically achievable concentrations of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of CPT-11, and blood sampled from patients with acute myeloid leukemia and chronic myeloid leukemia in myeloid blast transformation treated with CPT-11.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_provenance.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion evidence source_evidence_literature NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_provenance.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion SIO_000772 15956246 NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_provenance.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion wasDerivedFrom befree-2016 NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_provenance.
- NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_assertion wasGeneratedBy ECO_0000203 NP499488.RAc_mXYDEa5jTOj74NDqzBI9PftFysij__vV45w3RBiT4130_provenance.